- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
New Reimbursement Provisions a Big Boost for the Diet Industry
The lack of attention by mainstream medicine to the problems of overweight or obese patients have contributed to the burgeoning diet industry.
As obesity is increasingly being recognized as the underlying cause of many a disease, healthcare plans have changed their approach to the condition, especially folowing a provision within the Affordable Care Act. Insurers are now mandated to cover nutrition and obesity screening for their enrollees.
This has created a tremendous opportunity for diet clinics and resulted in an industry of sorts, which sometimes uses as yet unproven treatments like vitamin injections or dietary supplements that may not have been validated. The lack of attention by mainstream medicine to the problems of overweight or obese patients may have contributed to the burgeoning diet industry, says an article in The New York Times.
Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL
December 18th 2025The study suggests that adding a Bruton tyrosine kinase inhibitor (BTKi) to frontline chemoimmunotherapy in Richter transformation improved complete response rates and progression-free survival compared with chemoimmunotherapy alone, though overall survival benefits remained unclear.
Read More
